January 6, 2011 – Boston Scientific has completed its acquisition of transcatheter valve developer Sadra Medical.
January 6, 2011 - Healthcare spending in the United States grew 4 percent in 2009, to $2.5 trillion, or $8,086 per person, the slowest rate of growth in the 50-year history of the National Health Expenditure Accounts (NHEA). This was due in great part to the economic recession.
December 5, 2010 – Additional lots lots of the AngioSculpt Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Catheters are being recalled by the AngioScore Inc. The class I recall was originally initiated in December 2009, but the FDA reissued the alert in September.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 5, 2011 — The U.S. Food and Drug Administration (FDA) has given clearance for Medic Vision Ltd. to market its SafeCT product in the United States. SafeCT processes and enhances images spanning a broad range of clinical applications acquired on a wide variety of computed tomography (CT) scanners.
January 4, 2011 - The Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) yesterday announced the availability of registration for the Medicare and Medicaid electronic health record (EHR) reimbursement incentive programs.
January 4, 2010 – The U.S. Food and Drug Administration (FDA) has released an update of what medical devices it expects to be developed and brought to market within the next 10 years.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 4, 2011 - The Office of the National Coordinator for Health Information Technology (ONC) has issued a final rule to establish the permanent certification program for health information technology.
January 4, 2011 – An automated, digital blood pressure device is now available in the United States and Canada. The Connex ProBP 3400, from Welch Allyn, fits in the palm of the hand and provides a portable option for capturing reliable blood pressure readings in virtually any hospital or primary care environment.
January 3, 2011 — A portable viewing application that interfaces with an existing RIS/PACS/cardiology PACS for access to images and reports has been introduced.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 3, 2011 – Two new classes — “Advanced Computed Tomography (CT) Imaging for Technologists” and “Advanced Non-Contrast Magnetic Resonance Angiography (MRA)” — are being offered to educate technologists on the latest applications available with their Toshiba technology. They are offered by Toshiba America Medical Systems Inc.’s Education Center in Irvine, Calif.
January 3, 2011 – ev3, a Covidien company, has initiated a voluntary recall of specific lots of the NanoCross .014-inch Over-the-wire (OTW) peripheral transcatheter angioplasty (PTA) dilatation catheter due to the potential for the catheter shaft to crack or break during use.
January 3, 2011 – Arrow International, a division of Teleflex Medical, issued a class I recall, advising customers to immediately discontinue use of its Ultra 8 French intra-aortic balloon pump (IABP) catheters.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 29, 2010 - Research on reducing risks, improving medical treatment and improving lifestyle behaviors to fight the battle against heart disease and stroke are among the key scientific findings that make up this year's top cardiovascular and stroke research recognized by the American Heart Association/American Stroke Association.
December 29, 2010 – A new cardiac resynchronization therapy defibrillator (CRT-D) has been used in Canada for the first time. The Unify CRT-D, from St. Jude Medical, offers the smallest available device footprint in the industry. The devices’ narrower shape allows for shorter incision, leading to less time spent closing the incision and a smaller scar for the patient.
December 29, 2010 – Patient enrollment has been completed for a Phase III trial of an oral Factor Xa inhibitor. The ENGAGE AF-TIMI 48 study will investigate edoxaban, by Daiichi Sankyo, for preventing strokes and systemic embolic events (SEE) in patients with atrial fibrillation (AF).